Not available
Quote | UroGen Pharma Ltd. (NASDAQ:URGN)
Last: | $15 |
---|---|
Change Percent: | 0.0% |
Open: | $14.92 |
Close: | $15 |
High: | $15.2491 |
Low: | $14.56 |
Volume: | 175,784 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | UroGen Pharma Ltd. (NASDAQ:URGN)
2024-03-26 10:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-18 07:35:24 ET Summary JELMYTO revenues are growing but not by enough to support UroGen's operations. Guided financials show ongoing losses with adequate liquidity for its near term UGN-102 development. If all goes as hoped UroGen will launch UGN-102 in Q1, 2025. ...
Message Board Posts | UroGen Pharma Ltd. (NASDAQ:URGN)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
UroGen Pharma Ltd. Company Name:
URGN Stock Symbol:
NASDAQ Market:
2024-03-26 10:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE: ABBV) an...
2024-03-16 08:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...